Utility of Donor-Derived Cell Free DNA in Association With Gene Expression Profiling
Trial ID or NCT#
NCT02178943
Status
NOT RECRUITING
Purpose
Plasma donor-derived cell-free DNA (dd-cfDNA) is measured as a % of the total plasma cfDNA in association with the measurement of AlloMap, a non-invasive gene expression test to aid in heart transplant management.
Official Title
Utility of Donor-Derived Cell-free DNA in Association With Gene-Expression Profiling (AlloMap®) in Heart Transplant Recipients (D-OAR)
Eligibility Criteria
Ages Eligible for Study: Older than 15 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: Yes
Exclusion Criteria:
Investigator(s)
Kiran Khush
Heart failure cardiologist,
Cardiologist
Professor of Medicine (Cardiovascular Medicine)
Contact us to find out if this trial is right for you.
Contact
Helen Luikart
650-724-2883
View on ClinicalTrials.gov
